mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0003 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0004 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0005 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |